The Hidden Crisis of Diabetes in the Workplace: Beyond Sick Days and Spreadsheets
There’s a silent disruptor lurking in the cubicles and conference rooms of corporate Canada, and it’s not burnout or remote work fatigue. It’s diabetes. Personally, I think what makes this particularly fascinating is how diabetes has quietly climbed the ranks to become the second-largest driver of private drug spending in the country, just behind inflammatory conditions. But here’s the kicker: it’s not just a health issue—it’s a productivity crisis in disguise. According to a recent report by Express Scripts Canada, diabetes claims among adults aged 18 to 44—the backbone of the workforce—jumped by 6% in 2025. That’s not just a statistic; it’s a red flag for employers who are still treating diabetes management as a personal health matter rather than a strategic business concern.
The Mental Load of a 24/7 Condition
Managing diabetes is like running a marathon without a finish line. What many people don’t realize is that the mental toll of this 24/7 condition often makes it difficult for employees to act when it matters most. Sick days, for instance, are rarely treated as part of a larger pattern. Instead, they’re seen as isolated events. But here’s where it gets interesting: Manulife’s wellness data reveals that while absence accounts for just 3% of lost time, reduced productivity—think fatigue, errors, and cognitive fog—accounts for a staggering 19%. That adds up to 46 lost working days per employee per year. If you take a step back and think about it, that’s not just a health issue; it’s a systemic problem that demands a systemic solution.
Predictable Risks, Preventable Crises
One thing that immediately stands out is the concept of ‘predictable moments of risk.’ Gina Kawak, director of pharmacy benefits at Manulife, points out that illnesses—even minor ones like the flu—can destabilize diabetes management, leading to spikes in glucose levels and, in severe cases, hospitalizations. What this really suggests is that these moments aren’t random; they’re predictable inflection points. Yet, most employers, insurers, and clinicians are still playing catch-up, reacting to crises instead of building early intervention into the foundation of diabetes care. In my opinion, this reactive approach is not just inefficient—it’s costly, both in terms of health outcomes and workplace productivity.
The Role of Technology and Trust
A detail that I find especially interesting is the role of technology in diabetes management. Sensor-based glucose monitoring systems like Abbott’s FreeStyle Libre can deliver real-time feedback, driving behavioral change and reducing HbA1c levels comparable to adding medication. But here’s the catch: coverage for these tools is often restricted to patients already on insulin, leaving a critical gap in early intervention. This raises a deeper question: why are we waiting for diabetes to progress before providing access to tools that could prevent complications in the first place? From my perspective, this is a classic case of short-term cost-cutting leading to long-term expenses—both for individuals and for employers.
The Intersection of Privacy and Productivity
Diabetes management also sits at the intersection of workplace oversight and personal privacy. Emilie Vigneault-Simard, a specialized nurse practitioner, rightly points out that while sharing personal experiences can be valuable, it’s crucial to respect boundaries to avoid reinforcing stigma. This is where employers need to tread carefully. Managers, as Christine Than from Willis Towers Watson notes, are often the first to notice signs of struggle—fatigue, repeated errors, or frequent lateness. But intervention must be voluntary and trust-based. What many people don’t realize is that effective diabetes management in the workplace isn’t just about health; it’s about creating an environment where employees feel safe to seek support without fear of judgment or repercussions.
The Broader Implications: A Shift from Reaction to Anticipation
If we zoom out, the broader implication here is clear: diabetes management in the workplace needs to shift from reaction to anticipation. This means equipping employees with education, enabling early detection through technology, and ensuring timely access to care. Dr. Marie-Philippe Morin emphasizes that early glycemic control can reduce complications, care utilization, and workplace disruption. But here’s the challenge: how do we incentivize employers and insurers to invest in preventive measures when the ROI isn’t always immediate or measurable in traditional terms? Personally, I think this is where the real innovation lies—in redefining what ‘return on investment’ means when it comes to employee health.
Final Thoughts: A Call to Action
As I reflect on this, it’s clear that diabetes isn’t just a health issue; it’s a workplace issue, a productivity issue, and a societal issue. The opportunity is there for employers and insurers to reshape outcomes by treating predictable risks as preventable events. But it requires a fundamental shift in mindset—from viewing diabetes as a personal problem to recognizing it as a collective challenge. In my opinion, the organizations that lead this charge won’t just cut costs; they’ll build a healthier, more resilient workforce. And that, in the end, is the ultimate competitive advantage.
